Search results
New RSV shots tied to rare nervous system disorder — should you worry?
Live Science via Yahoo News· 11 hours agoThere's been some reports of Guillain-Barré syndrome in older adults who got the vaccines. But...
Moderna’s flu-COVID combo shot hits goal in late-stage trial - Indianapolis Business Journal
Indianapolis Business Journal· 4 days agoModerna Inc. said its combination flu and COVID shot met the goals of a pivotal late-stage trial,...
Results are looking promising for a combined COVID and flu vaccine. Here’s how it could benefit...
The Conversation· 3 hours agoEarlier this week, Moderna announced positive results for its phase 3 clinical trial of a combined vaccine against COVID and influenza. Combination vaccines
Bridgeway Capital Management LLC Boosts Stock Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 21 hours agoBridgeway Capital Management LLC boosted its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 26.0% during the 4th quarter, according to its most recent 13F filing ...
New COVID Vaccines Targeting JN.1 Will Arrive This Fall
Verywell Health via Yahoo News· 7 days agoVaccine manufacturers, including Pfizer, Moderna, and Novavax, have already been working on a JN.1...
Weik Capital Management Sells 10,839 Shares of Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 5 days agoWeik Capital Management decreased its position in Pfizer Inc. (NYSE:PFE – Free Report) by 26.3% in the 4th quarter, according to the company in its most recent filing with ...
Another COVID vaccine? Yes, and here’s why
Denver Post· 3 days agovaccine has been shown to reduce the risk of having to go to the doctor with flu by 40% to 60%.” Last Wednesday, FDA’s advisers, a panel of physicians...
Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with...
Morningstar· 1 day agoPfizer Inc. (NYSE: PFE) today announced that CIFFREO, a Phase 3 global, multicenter, randomized, double-blind, placebo-controlled study evaluating the investigational mini-dystrophin ...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoMethylmalonic acidemia is a rare, genetic disease that prevents the body from breaking down proteins...
COVID Variant KP.3 Surges to Dominance—Here's What You Need to Know
Health via Yahoo News· 16 hours agoCases are “stable or uncertain” in 18 others and are likely declining in one—Oklahoma. Do Vaccines...